Gene-centric analysis of serum cotinine levels in African and European American populations

Neuropsychopharmacology

Volumn 37, Issue 4, 2012, Pages 968-974

  Hamidovic, Ajna ^a   Goodloe, Robert J ^b   Bergen, Andrew W ^c   Benowitz, Neal L ^d   Styn, Mindi A ^e   Kasberger, Jay L ^f   Choquet, Helene ^d   Young, Taylor R ^g   Meng, Yan ^g   Palmer, Cameron ^g   Pletcher, Mark ^d   Kertesz, Stefan ^h   Hitsman, Brian ^a   Spring, Bonnie ^a   Jorgenson, Eric ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SRI INTERNATIONAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h University of Alabama at Birmingham   (United States)

Author keywords

CARDIA; cotinine; IDE; IMAT Broad CARe; MORF4L1; nicotine

Indexed keywords

COTININE; DOPAMINE; INSULIN; INSULINASE;

ADULT; AFRICAN AMERICAN; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY RISK; DOPAMINERGIC TRANSMISSION; EUROPEAN AMERICAN; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; INTRON; MALE; MICROCHIP ANALYSIS; NORMAL HUMAN; PHENOTYPE; POPULATION; PRIORITY JOURNAL; REWARD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; COTININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84857052848     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.280     Document Type: Article

References (49)

1. Baskin DG, Schwartz MW, Sipols AJ, D'Alessio DA, Goldstein BJ, White MF (1994). Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology 134: 1952-1955. (Pubitemid 24110760)
2. Bergen AW, Caporaso N (1999). Cigarette smoking. J Natl Cancer Inst 91: 1365-1375. (Pubitemid 29399994)
3. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ et al. (1998). Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA 280: 135-139. (Pubitemid 28498384)
4. Cashman JR, Park SB, Yang ZC, Wrighton SA, Jacob 3rd P, Benowitz NL (1992). Metabolism of nicotine by human liver microsomes: Stereoselective formation of trans-nicotine N'-oxide. Chem Res Toxicol 5: 639-646.
5. Clark PI, Gautam SP, Hlaing WM, Gerson LW (1996). Response error in self-reported current smoking frequency by black and white established smokers. Ann Epidemiol 6: 483-489. (Pubitemid 27008653)
6. English PB, Eskenazi B, Christianson RE (1994). Black-white differences in serum cotinine levels among pregnant women and subsequent effects on infant birthweight. Am J Public Health 84: 1439-1443.
7. Farris W, Leissring MA, Hemming ML, Chang AY, Selkoe DJ (2005). Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein. Biochemistry 44: 6513-6525. (Pubitemid 40593802)
8. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP et al. (2003). Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-Amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100: 4162-4167. (Pubitemid 36418174)
9. Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB et al. (2004). Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164: 1425-1434. (Pubitemid 38387808)
10. Garcia BG, Wei Y, Moron JA, Lin RZ, Javitch JA, Galli A (2005). Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 68: 102-109. (Pubitemid 41002948)
11. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M (2009). The accuracy of self-reported smoking: A systematic review of the relationship between self-reported and cotinineassessed smoking status. Nicotine Tob Res 11: 12-24.
12. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE et al. (2006). Ethnic and racial differences in the smoking-related risk of lung cancer. N Eng J Med 354: 333-342. (Pubitemid 43145058)
13. Haley NJ, Axelrad CM, Tilton KA (1983). Validation of selfreported smoking behavior: Biochemical analyses of cotinine and thiocyanate. Am J Public Health 73: 1204-1207. (Pubitemid 13001213)
14. He Y, Bergen AW, Hops H, Andrews JA, Tildesley E, Lessov-Schlaggar CN et al. (2009). Genome-wide linkage of cotinine pharmacokinetics suggests candidate regions on chromosomes 9 and 11. Am J Med Genet B Neuropsychiatr Genet 150B: 554-559.
15. Hodgkinson CA, Yuan Q, Xu K, Shen P-H, Heinz E, Lobos EA et al. (2008). Addictions biology: Haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43: 505-515.
16. Huang L, Li Y, Singleton AB, Hardy JA, Abecasis G, Rosenberg NA et al. (2009). Genotype-imputation accuracy across worldwide human populations. Am J Hum Genet 84: 235-250.
17. Hukkanen J, Jacob 3rd P, Benowitz NL (2005). Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57: 79-115. (Pubitemid 40283970)
18. Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y (1984). Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health 38: 335-339. (Pubitemid 15194784)
19. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT et al. (2008). Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE 3: E3583.
20. Keskitalo K, Broms U, Heliovaara M, Ripatti S, Surakka I, Perola M et al. (2009). Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/ CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet 18: 4007-4012.
21. Kurochkin IV, Goto S (1994). Alzheimer's beta-Amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345: 33-37.
22. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, et al., Wellcome Trust Case Control Consortium (2010). Metaanalysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 42: 436-440.
23. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB et al. (2003). Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100: 6221-6226. (Pubitemid 36576957)
24. Musunuru K, Lettre G, Young T, Farlow DN, Pirruccello JP, Ejebe KG et al. (2010). Candidate gene association resource (CARe): Design, methods, and proof of concept. Circ Cardiovas Genet 3: 267-275.
25. Mwenifumbo JC, Zhou Q, Benowitz NL, Sellers EM, Tyndale RF (2010). New CYP2A6 gene deletion and conversion variants in a population of Black African descent. Pharmacogenomics 11: 189-198.
26. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K et al. (1996). Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24: 1212-1217. (Pubitemid 26423061)
27. Owens WA, Sevak RJ, Galici R, Chang X, Javors MA, Galli A et al. (2005). Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem 94: 1402-1410. (Pubitemid 41232595)
28. Pattishall EN, Strope GL, Etzel RA, Helms RW, Haley NJ, Denny FW (1985). Serum cotinine as a measure of tobacco smoke exposure in children. Am J Dis Child 139: 1101-1104. (Pubitemid 16258035)
29. Perez-Stable EJ, Herrera B, Jacob 3rd P, Benowitz NL (1998). Nicotine metabolism and intake in black and white smokers. JAMA 280: 152-156. (Pubitemid 28498387)
30. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909. (Pubitemid 44141658)
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. (Pubitemid 47330214)
32. QiuW,Walsh D, Ye Z, Vekrellis K, Zhang J, Podlisny M et al. (1998). Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273: 32730-32738. (Pubitemid 28557658)
33. Qiu WQ, Folstein MF (2006). Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: Review and hypothesis. Neurobiol Aging 27: 190-198. (Pubitemid 43038542)
34. Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M et al. (2008). SEER Cancer Statistics Review, 1975-2005. National Cancer Institute: Bethesda, MD.
35. Smith RM, Alachkar H, Papp AC, Wang D, Mash DC, Wang J-C et al. (2011). Nicotinic alpha-5 receptor subunit mRNA expression is associated with distant 50 upstream polymorphisms. Eur J Hum Genet 19: 76-83.
36. Sugano T, Yanagita T, Yokoo H, Satoh S, Kobayashi H, Wada A (2006). Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-Alpha/ ERK pathway: Up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells. J Neurochem 98: 20-33. (Pubitemid 43882929)
37. Swan GE, Lessov-Schlaggar CN, Bergen AW, He Y, Tyndale RF, Benowitz NL (2009). Genetic and environmental influences on the ratio of 30hydroxycotinine to cotinine in plasma and urine. Pharmacogenetics Genomics 19: 388-398.
38. Taguchi A, Wartschow LM, White MF (2007). Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317: 369-372. (Pubitemid 47106376)
39. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al. (2008). A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642. (Pubitemid 351483366)
40. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F et al. (2010). Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42: 448-453.
41. Tobacco and Genetics Consortium (2010). Genome-wide metaanalyses identify multiple loci associated with smoking behavior. Nat Genet 42: 441-447.
42. VanVunakis H, Gjika H, Langone J (1987). Method 16-Radioimmunoassay for nicotine and cotinine. In: O'Neill I, Brunnemann K, Dodet B, Hoffman D (ed). Environmental Carcinogens Methods of Analysis and Exposure Measurement. Volume 9-Passive Smoking, IARC, pp 317-330.
43. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V et al. (2000). Neurons regulate extracellular levels of amyloid betaprotein via proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657-1665. (Pubitemid 30220363)
44. Vepsalainen S, Parkinson M, Helisalmi S, Mannermaa A, Soininen H, Tanzi RE et al. (2007). Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population. J Med Genet 44: 606-608. (Pubitemid 47441771)
45. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH et al. (1990). Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health 80: 1053-1056. (Pubitemid 20261378)
46. Wang J, Kim J, Donovan D, Becker K, Li M (2009). Significant modulation of mitochondrial electron transport system by nicotine in various rat brain regions. Mitochondrion 9: 186-195.
47. Wang JC, Li MD (2010). Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. Neuropsychopharmacology 35: 702-719.
48. Wang K, Hackett JT, Cox ME, Van Hoek M, Lindstrom JM, Parsons SJ (2004). Regulation of the neuronal nicotinic acetylcholine receptor by SRC family tyrosine kinases. J Biol Chem 279: 8779-8786. (Pubitemid 38295935)
49. Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD et al. (2007). Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. Plos Biol 5: E274.